Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, Non-Hodgkin 1Lymphoma, B-Cell 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Hodgkin Disease 1

Interventions

Cyclophosphamide 7Mycophenolic Acid 5Whole-Body Irradiation 4Busulfan 4fludarabine phosphate 3fludarabine 3Tacrolimus 3Rituximab 3Prednisone 3Methotrexate 3Inotuzumab Ozogamicin 3Etoposide 3Cytarabine 3Cyclosporine 3venetoclax 2ruxolitinib 2pegfilgrastim 2asciminib 2Vincristine 2Peripheral Blood Stem Cell Transplantation 2Mercaptopurine 2Filgrastim 2Dexamethasone 2Calcium Dobesilate 2tocilizumab 1ricolinostat 1rasburicase 1ponatinib 1pembrolizumab 1pegylated granulocyte colony-stimulating factor, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Influenza Vaccines × 30 days × Clear all
NCT01135329 2026-05-27

Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated
15 enrolled 8 charts
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡